A Single-dose Crossover Study of Fentanyl Sublingual Spray 400 Mcg Versus Actiq 400 Mcg Versus Fentanyl Citrate Injection (iv) 100 Mcg Under Fasted Conditions

Trial Profile

A Single-dose Crossover Study of Fentanyl Sublingual Spray 400 Mcg Versus Actiq 400 Mcg Versus Fentanyl Citrate Injection (iv) 100 Mcg Under Fasted Conditions

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2014

At a glance

  • Drugs Fentanyl (Primary) ; Fentanyl (Primary) ; Fentanyl (Primary) ; Naltrexone
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors INSYS Pharma
  • Most Recent Events

    • 08 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top